Stay updated on CPX-351 and Ivosidenib in IDH1 AML Clinical Trial

Sign up to get notified when there's something new on the CPX-351 and Ivosidenib in IDH1 AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CPX-351 and Ivosidenib in IDH1 AML Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page revision indicator was updated from v3.5.2 to v3.5.3, reflecting a change to the site’s display/versioning rather than the underlying clinical trial record content.
    Difference
    0.1%
    Check dated 2026-04-24T16:45:55.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 to the history. Deleted Revision: v3.5.0 from the history.
    Difference
    0.1%
    Check dated 2026-04-17T13:47:40.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    A new version entry was added on 2025-11-20 showing updated study status and recruitment details. The history now reflects the latest changes to the trial record.
    Difference
    0.1%
    Check dated 2026-04-03T05:33:42.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Revision history now includes the addition of v3.5.0 and the deletion of v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T22:23:15.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added to the history and Revision: v3.4.2 was removed. This update reflects administrative changes to the record history.
    Difference
    0.1%
    Check dated 2026-03-12T20:23:39.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 to the history, and removed the site-wide funding/operating-status notice along with the prior Revision: v3.4.1 entry. These changes relate to site-wide notices and version labeling rather than the core study content.
    Difference
    0.7%
    Check dated 2026-02-11T21:15:48.000Z thumbnail image

Stay in the know with updates to CPX-351 and Ivosidenib in IDH1 AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CPX-351 and Ivosidenib in IDH1 AML Clinical Trial page.